Blood Transfusion Diagnostics Market Types and Applications, Outlook, Industry Drivers, Ongoing Trends, Future Demand, Challenges, Top Companies and Forecast 2028

The global Blood Transfusion Diagnostics Market is expected to grow from US$ 4,096.93 million in 2021 to US$ 6,483.75 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2022 to 2028. The report highlights prevailing trends and factors driving the market growth.

The growth of the global blood transfusion diagnostics market is attributed to the rapid increase in chronic diseases and the need for blood transfusion due to the rise in organ transplant surgeries. However, the problems associated with blood transfusion services hinder the overall market growth.

Get Exclusive Sample PDF @: https://www.premiummarketinsights.com/sample/TIP00014936?utm_source=OpenPr&utm_medium=10640

Analysis of the Top Market Players:

1. Grifols, S.A.
2. F. Hoffmann-La Roche Ltd
3. Immucor, Inc.
4. Bio-Rad Laboratories Inc.
5. Abbott
6. Thermo Fisher Scientific Inc.
7. Ortho Clinical Diagnostics
8. DiaSorin S.p.A.
9. Quotient Limited
10. BAG Diagnostics GmbH

In this report, the market has been segmented on the basis of:

Product (Instruments & Kits and Reagents)
Application (Disease Screening and Blood Grouping)
End User (Hospitals, Diagnostic Laboratories, and Plasma Fractionation Companies)

Get full Report Description, TOC, Table of Figure, Chart, etc. @: https://www.premiummarketinsights.com/reports-tip/blood-transfusion-diagnostics-market

Blood transfusion diagnostics refers to tests performed on blood and blood components before they are transfused to patients. A blood transfusion is a common procedure in which donated blood or blood components are transfused into the patient's body through an intravenous line (IV). Each unit of blood must undergo blood typing, which refers to identification of blood type and blood screening, including disease detection tests to avoid side effects or transmission of infection. Blood screening before transfusion is performed through instruments, kits, and reagents to identify various diseases, such as HIV, hepatitis B, hepatitis C, Zika, and different viruses and infections.

According to the data published by the National Institute of Cancer Prevention and Research (NICPR) and the Indian Council of Medical Research (ICMR), the yearly prevalence of cancer in India is estimated at ~2.25 million, leading to numerous surgical procedures.

Buy this research report at @: https://www.premiummarketinsights.com/buy/TIP00014936?utm_source=OpenPr&utm_medium=10640

Contact Us:
If you have any queries about this report or if you would like further information, please
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
Email: sales@premiummarketinsights.com

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

This release was published on openPR.